Andrew Muir
Keine laufenden Positionen mehr
Profil
Andrew R.
Muir served as Chairman at Select Therapeutics, Inc. He was also a Director at Satcon Technology Corp.
from 2004 to 2007.
Additionally, he served as a Non-Executive Director at Christie Group Plc.
Dr. Muir holds a doctorate from the University of Oxford and an MBA from Pace University.
Ehemalige bekannte Positionen von Andrew Muir
| Unternehmen | Position | Ende |
|---|---|---|
| SATCON TECHNOLOGY CORPORATION | Direktor/Vorstandsmitglied | 20.12.2007 |
| CHRISTIE GROUP PLC | Direktor/Vorstandsmitglied | 27.06.2005 |
Select Therapeutics, Inc.
 Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Vorsitzender | - |
Ausbildung von Andrew Muir
| Pace University | Masters Business Admin |
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHRISTIE GROUP PLC | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Satcon Technology Corp.
 Satcon Technology Corp. SemiconductorsElectronic Technology Satcon Technology Corp. operates as a energy and power company. It provides system design services for utility-scale renewable energy plants. The firm designs and delivers advanced power conversion solutions that enable producers of renewable energy to convert clean energy into grid-connected and reliable electrical power. The company was founded by David B. Eisenhaure in February 1985 and is headquartered in Boston, MA. | Electronic Technology |
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Health Technology |
